Cargando…

Fluciclovine positron emission tomography in the setting of biochemical recurrence following local therapy of prostate cancer

Approximately one in five men will demonstrate biochemical recurrence (BCR) following local therapy for prostate cancer (PCa). Advanced imaging modalities including positron emission tomography (PET) imaging of various radiotracers have become more commonplace to visualize foci of disease recurrence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Glaser, Zachary A., Rais-Bahrami, Soroush
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212627/ https://www.ncbi.nlm.nih.gov/pubmed/30456185 http://dx.doi.org/10.21037/tau.2018.07.17

Ejemplares similares

(18)F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic review
por: Rais-Bahrami, Soroush, et al.
Publicado: (2021)

Feasibility of Dose Escalating [(18)F]fluciclovine Positron Emission Tomography Positive Pelvic Lymph Nodes During Moderately Hypofractionated Radiation Therapy for High-Risk Prostate Cancer
por: McDonald, Andrew M., et al.
Publicado: (2019)

Salvage Pelvic Lymph Node Dissection After Fluciclovine Positron Emission Tomography/Computed Tomography Detected Prostate Cancer Recurrence
por: Cancian, Madeline, et al.
Publicado: (2018)

Simultaneous (18)F-fluciclovine Positron Emission Tomography and Magnetic Resonance Spectroscopic Imaging of Prostate Cancer
por: Esmaeili, Morteza, et al.
Publicado: (2018)

Imaging Glioblastoma With (18)F-Fluciclovine Amino Acid Positron Emission Tomography
por: Scarpelli, Matthew L., et al.
Publicado: (2022)

[(18)F]fluciclovine vs. [(18)F]fluorocholine Positron Emission Tomography/Computed Tomography: A Head-to-Head Comparison for Early Detection of Biochemical Recurrence in Prostate Cancer Patients
por: Ferrari, Cristina, et al.
Publicado: (2022)

18F-Fluciclovine Positron Emission Tomography in Prostate Cancer: A Systematic Review and Diagnostic Meta-Analysis
por: Biscontini, Giuseppina, et al.
Publicado: (2021)

Axumin Positron Emission Tomography: Novel Agent for Prostate Cancer Biochemical Recurrence
por: Songmen, Swachchhanda, et al.
Publicado: (2019)

Localization and restaging of carcinoma prostate by (68)Gallium prostate-specific membrane antigen positron emission tomography computed tomography in patients with biochemical recurrence
por: Seniaray, Nikhil, et al.
Publicado: (2020)

Initial Institutional Experience with 18F-Fluciclovine PET-CT in Biochemical Recurrence of Prostate Cancer
por: Farkas, Amy B., et al.
Publicado: (2021)

Comparison of time curves from dynamic (18)F-fluciclovine positron emission tomography and dynamic contrast-enhanced magnetic resonance imaging for primary prostate carcinomas
por: Tulipan, Andreas Julius, et al.
Publicado: (2018)

Texture Analysis of F-18 Fluciclovine PET/CT to Predict Biochemically Recurrent Prostate Cancer: Initial Results
por: Kang, Hakmook, et al.
Publicado: (2020)

Defining Prostatic Vascular Pedicle Recurrence and the Anatomy of Local Recurrence of Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography
por: Dundee, Philip, et al.
Publicado: (2022)

Detection of Recurrent Prostate Cancer With (18)F-Fluciclovine PET/MRI
por: Selnæs, Kirsten Margrete, et al.
Publicado: (2020)

Cost–consequence analysis of (18)F-fluciclovine for the staging of recurrent prostate cancer
por: Jensen, Ivar S, et al.
Publicado: (2020)

Initial experience of Ga-68 prostate-specific membrane antigen positron emission tomography/computed tomography imaging in evaluation of biochemical recurrence in prostate cancer patients
por: Natarajan, Aravintho, et al.
Publicado: (2019)

Role of molecular imaging in the detection of localized prostate cancer
por: Galgano, Samuel J., et al.
Publicado: (2022)

Understanding and Improving (18)F-Fluciclovine PET/CT Reports: A Guide for Physicians Treating Patients with Biochemical Recurrence of Prostate Cancer
por: Lowentritt, Benjamin H., et al.
Publicado: (2020)

Prostate Cancer Imaging and Biomarkers Guiding Safe Selection of Active Surveillance
por: Glaser, Zachary A., et al.
Publicado: (2017)

Level Set Method for Positron Emission Tomography
por: Chan, Tony F., et al.
Publicado: (2007)

Positron Emission Tomography-Computed Tomography Coregistration for Diagnosis and Intraoperative Localization in Recurrent Nelson Syndrome
por: Hintz, Eric B., et al.
Publicado: (2013)

Dose-Escalated Salvage Radiotherapy for Macroscopic Local Recurrence of Prostate Cancer in the Prostate-Specific Membrane Antigen Positron Emission Tomography Era
por: Tamihardja, Jörg, et al.
Publicado: (2022)

MRI findings guiding selection of active surveillance for prostate cancer: a review of emerging evidence
por: Glaser, Zachary A., et al.
Publicado: (2018)

Diagnostic Performance and Safety of Positron Emission Tomography Using (18)F-Fluciclovine in Patients with Clinically Suspected High- or Low-grade Gliomas: A Multicenter Phase IIb Trial
por: Wakabayashi, Toshihiko, et al.
Publicado: (2017)

Positron emission tomography
Publicado: (1995)

Positron Emission Tomography
por: Piepmeier, Joseph M.
Publicado: (1986)

Positron emission tomography
por: Paans, A M J
Publicado: (2006)

[(18)F]Fluciclovine PET/CT Improves the Clinical Management of Early Recurrence Prostate Cancer Patients
por: Nappi, Anna Giulia, et al.
Publicado: (2022)

Positron emission tomography alone, positron emission tomography-computed tomography and computed tomography in diagnosing recurrent cervical carcinoma: a systematic review and meta-analysis
por: Xiao, Yi, et al.
Publicado: (2014)

Personalized prostate cancer care
por: Rais-Bahrami, Soroush, et al.
Publicado: (2018)

Diagnosis of prostatitis by 18-F-fluorodeoxyglucose positron emission tomography
por: Ho, Thien Anh, et al.
Publicado: (2009)

Imaging Cellular Proliferation in Prostate Cancer with Positron Emission Tomography
por: Jadvar, Hossein
Publicado: (2015)

Positron emission tomography in prostate cancer: An update on state of the art
por: Das, Chandan Jyoti, et al.
Publicado: (2018)

Nodular fasciitis mimicking recurrent lymphoma on positron emission tomography–computed tomography
por: Zhou, Qiao, et al.
Publicado: (2016)

Diagnostic role of fluorodeoxyglucose positron emission tomography-computed tomography in prostate cancer
por: LIU, YIYAN
Publicado: (2014)

Upgrading prostate cancer following proton beam therapy
por: Logan, Jennifer K., et al.
Publicado: (2015)

Follow-up of incidental findings on positron emission tomography
por: Lee, Joseph C., et al.
Publicado: (2020)

The Diagnostic Role of (18)F-Choline, (18)F-Fluciclovine and (18)F-PSMA PET/CT in the Detection of Prostate Cancer With Biochemical Recurrence: A Meta-Analysis
por: Wang, Rang, et al.
Publicado: (2021)

Positron emission tomography: An overview
por: Shukla, A. K., et al.
Publicado: (2006)

Scintillators for positron emission tomography
por: Moses, W W, et al.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_ahlsrsh8d1ueg6k160resb77f7